MyZA

News, Directory, Events and Other Stuff

You are here: Home / Archives for Vaccines

Vaccines

NICD warns of increase in cases of respiratory diphtheria

Location: News

NICD warns of increase in cases of respiratory diphtheria

The National Institute for Communicable Diseases (NICD) has urged citizens to check their children’s vaccination status due to a rise in diphtheria cases in the country.

Since the beginning of 2025, up until 23 March, diphtheria, caused by the bacterium Corynebacterium diphtheriae, has been confirmed in 40 people in South Africa.

Of these cases, 19 exhibited symptoms, while 21 were asymptomatic.

“These asymptomatic individuals were carriers identified during contact tracing,” the statement read.

According to data from the NICD, there were 15 reported cases of respiratory diphtheria in the Western Cape, two cases in Gauteng, three cases in Mpumalanga, and one probable case in Limpopo.

Laboratory tests did not confirm the case from Limpopo, but the person exhibited symptoms consistent with respiratory diphtheria.

Over 78% of the cases have occurred in adults aged 18 and older.

Among the symptomatic cases, the public health institute said it was important to note that nine people have died, resulting in a case fatality rate of 27% (nine out of 33 cases) since the beginning of 2024.

“Adults who have not had a diphtheria vaccine in the last 10 years are urged to seek vaccination at a clinic or with their usual healthcare provider.

“Pregnant women are advised to get the vaccine with each pregnancy to protect the baby from diphtheria, tetanus, and pertussis.”

Diphtheria is a contagious, severe, vaccine-preventable illness usually associated with a sore throat, fever, and large, swollen glands in the neck.

The NICD said this illness is sometimes called a “bull neck”, and on examining a patient, the doctor will see a characteristic adherent membrane over the tonsils and the throat, also known as a “pseudomembrane”.

“If not treated early, the public health institute said diphtheria causes difficulty in breathing and can lead to complete blockage of the airway and death. The organism also produces a toxin that affects the heart muscle, kidneys, and nervous system, leading to life-threatening illness.”

Treatment is with diphtheria antitoxin to neutralise the toxin produced by the bacterium and appropriate antibiotics to eradicate the organism, which should be given early to be effective.

The NICD is encouraging doctors and healthcare workers to be on high alert for suspected diphtheria cases and are urged to report cases on the Notifiable Medical Condition app or the NICD website.

The NICD said the best protection against diphtheria is vaccination.

Infant vaccine is given at six, 10, and 14 weeks of age, with booster doses at 18 months and six and 12 years.

The available vaccines include Dt (diphtheria and tetanus) and DTaP (diphtheria, tetanus, and acellular pertussis or whooping cough). – SAnews.gov.za 
 

 

Gabisile
Mon, 03/31/2025 - 09:41
 443 views

Read moreNICD warns of increase in cases of respiratory diphtheria

Call to scale up cervical cancer interventions 

Location: News

Call to scale up cervical cancer interventions 

The international community has been called upon to scale up cervical cancer interventions and progress against the only noncommunicable disease that can be eliminated. 

This call was made by the Government of South Africa, Unitaid and the World Health Organization (WHO) at the Group of Twenty (G20) Health Working Group meeting, which took place on Thursday in Zimbali, outside Durban.  

According to the Department of Health, cervical cancer is preventable and potentially curable, as long as it is detected early and managed effectively. It is the second most common form of cancer among women in South Africa. 

Statistics by the WHO show that the disease claimed the lives of almost 350 000 women globally in 2022.

“New vaccines, tests, and treatment technologies have transformed cervical cancer prevention in recent years, yet the disease continues to disproportionately impact women mostly in low- and middle-income countries where access to primary health care and preventive services are limited. Cervical cancer elimination would address a major gap in Women’s health,” the department said.

Speaking on the sidelines of the G20 health meeting, Unitaid’s Deputy Executive Director Tenu Avafia said Unitaid has invested US $81 million or R1.4 billion to bring down prices, increase volumes and address operational questions involved in cervical cancer screening and treatment to enable countries to scale up proven interventions with minimal risk.

“However, funding shortfalls still pose enormous challenges to building national cervical cancer elimination programs in low- and middle-income countries,” Avafia said.

Unitaid makes health products accessible, available and affordable for people who need them most.

Department of Health’s Director-General Dr Sandile Buthelezi said improving women’s health was not just a health issue but “an economic imperative”.

“It drives social stability, boosts productivity, and breaks the cycle of poverty. Global efforts to combat cervical cancer serve as a concrete illustration of how cooperation can advance women’s health and realize a shared goal to bring about the first-ever elimination of a cancer,” he said.

In 2020, the WHO launched the global strategy for cervical cancer elimination, the first-ever roadmap for the elimination of a cancer. Since then, countries have made enormous strides in rolling out new tools and services. 

Vaccination against Human Papillomavirus (HPV) provides protection against infection that causes nearly all cases of cervical cancer. 

And a package of screening and treatment tools – including HPV tests with the option for self-sampling and devices for quickly and easily removing pre-cancerous cells – make it possible to make lifesaving services available to women at lower levels of the health care system.

The health working group session called for a coordinated approach drawing on domestic resource mobilization, blended financing, and partnerships with multilateral development banks to scale these solutions, ensure long-term sustainability and reduce dependency on external aid.

Government asserted South Africa’s commitment to scaling up cervical cancer prevention programs nationwide with support from Unitaid, the WHO and other partners.

“The South African G20 health agenda promotes solidarity, equality and sustainability. It complements the African Union’s Agenda 2063, the development agenda of Africa as the world’s fastest-growing continent, and the Lusaka Agenda. It also focuses on rebuilding momentum to reach the 2030 Sustainable Development Goals (SDGs),” the department said.

On Wednesday, Health Minister Dr Aaron Motsoaledi reiterated the importance of nations reallocating resources towards health, strengthening global health partnerships, and exploring innovative financing mechanisms to address funding gaps.

READ | Motsoaledi urges global action to address health funding gaps

The Minister used the platform to highlight South Africa’s commitment to universal health coverage (UHC) through the National Health Insurance (NHI) system, which aims to provide financial protection and efficient resource utilisation.

The three-day meeting which began on Wednesday, will conclude on Friday, 28 March 2025. - SAnews.gov.za

nosihle
Fri, 03/28/2025 - 10:13
 28 views

Read moreCall to scale up cervical cancer interventions 

WHO Injects Fresh Support Into DRC Vaccination Drive

Location: News

UN News
Download logo

The UN World Health Organization (WHO) has stepped up efforts to improve vaccination coverage in the Democratic Republic of the Congo (DRC) by providing vital logistical support, including boats and motorcycles to reach remote communities along the Congo River. 

The initiative aims to curb the spread of preventable diseases such as polio, measles and yellow fever which remain a persistent threat in hard-to-reach areas.

Speedy response

WHO delivered 79 outboard motors, two speedboats, 14 motorcycles and other essential equipment worth $750,000 to the country's Ministry of Public Health to expand vaccination campaigns in 89 health zones in nine provinces, the agency said in a news release on Tuesday (in French).

“These boats and vehicles will allow health workers to quickly reach children and communities who have long been cut off from essential services,” said Boureima Hama Sambo, WHO Representative in the DRC.

“This will significantly reduce the number of missed vaccinations and ensure that no child is left vulnerable to diseases that we can prevent.”

Fighting preventable diseases

The Congo River and its many tributaries form a vast network of isolated islands and remote settlements, particularly in provinces such as Équateur, Mongala, Tanganyika and Tshopo.

Many of these areas host large numbers of unvaccinated children, leading to repeated outbreaks of polio, measles and yellow fever, according to WHO.

In 2024, the DRC confirmed 25 cases of circulating variant poliovirus (types 1 and 2) and reported more than 102,500 suspected measles cases, resulting in over 2,200 deaths. Meningitis also remains a major concern, with 5,837 suspected cases and 465 deaths last year.

The WHO and DRC authorities have been working to address these challenges through mass immunization campaigns.

“Improving the availability of vaccines and other vital health supplies in the Expanded Programme on Immunization (EPI) branches, health zones and areas, is essential to strengthening the health system and implementing advanced and mobile vaccination strategies. Integration with other health services will make a difference, bringing significant benefits to the most vulnerable populations,” said Dr. Sambo.

Ongoing Mpox outbreak

Even as the country battles vaccine-preventable diseases, the DRC continues to face a large mpox outbreak. Between 1 January and 2 March 2025, the country recorded 2,415 confirmed cases, with 1,080 of them occurring in the last six weeks alone.

WHO has declared the mpox resurgence a public health emergency of international concern (PHEIC) and warned that the virus is circulating in at least ten provinces.

The outbreak is being fuelled by sustained human-to-human transmission, particularly in the capital, Kinshasa, where genomic sequencing indicates that one specific strain has persisted since July 2024.

Impact of violence

Complicating response efforts is the ongoing violence in the eastern DRC, which disrupted healthcare services and made it difficult to track and contain the virus. In February, the virus was detected for the first time in the south-central Lomami province, expanding its reach further.

The WHO is also monitoring new travel-related mpox cases that have emerged outside the country, including in Belgium, France, Germany, the United Kingdom and the United States.

Meanwhile, South Africa has reported its first cluster of mpox cases linked to the same strain circulating in the DRC.

Distributed by APO Group on behalf of UN News.

Read moreWHO Injects Fresh Support Into DRC Vaccination Drive

Call for vigilance as new Mpox cases surface

Location: News

Call for vigilance as new Mpox cases surface

The Department of Health has issued a call for heightened awareness among the public as three new laboratory-confirmed cases of Mpox have been detected. 

According to the department, the first case, identified on 21 February 2025, involves a 30-year-old male residing in Ekurhuleni, Gauteng, who recently travelled to Kampala, Uganda. 

“The patient was diagnosed with Grade I Mpox virus, which is currently circulating in the Democratic Republic of Congo and Uganda and has been reported in travellers returning to many locations around the globe,” the statement read. 

The other two confirmed cases - a 30-year-old male and a 27-year-old female, both from Ekurhuleni, were identified through thorough contact tracing and monitoring efforts led by outbreak response teams.

The department believes this development highlights the vital importance of open communication from primary cases to facilitate effective contact tracing. 

“All three cases are now recovering and self-isolating at home,” said the department.

The latest statistics bring the total cumulative number of positive cases from 25 to 28 cases, including three deaths since the outbreak in May last year.

Meanwhile, these are the first positive cases of Mpox recorded in South Africa this year after the last infection was reported in September 2024. 

Globally, Mpox continues to be a Public Health Emergency of International Concern (PHEIC) and a Public Health Emergency of Continental Security (PHECS) as per the declarations by both the World Health Organisation (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) in August 2024.

While the department assures that there is no need for public alarm, it stressed the importance of remaining vigilant regarding the transmission of Mpox. 

Symptoms to watch for include a rash lasting two to four weeks, fever, headache, muscle aches, back pain, fatigue, and swollen glands. 

Generally, Mpox presents as a mild, self-limiting disease with a low case fatality rate. 

The risk of widespread transmission in South Africa at this time is considered low; however, the department said the disease can affect individuals across all ages, genders, sexual orientations, and races.

“The department urges all people experiencing any of the symptoms, with or without travel history to countries and regions experiencing Mpox outbreaks, or who had close contact with known Mpox patients to seek medical care.

“Although, the country has a limited stock of Mpox-specific vaccines for the treatment of patients who experience severe health complications as a result of this disease,” it said.

Residents were also reminded to practice handwashing with soap and water or alcohol-based hand sanitisers, especially before eating or after using the restroom, to help mitigate the spread of the disease. – SAnews.gov.za

 

Gabisile
Fri, 02/28/2025 - 16:06
 69 views

Read moreCall for vigilance as new Mpox cases surface

NICD calls for calm amidst reported HMPV cases in China

Location: News

NICD calls for calm amidst reported HMPV cases in China

The National Institute for Communicable Diseases (NICD) has issued a statement assuring the public that there is no need to panic about the reported cases of human metapneumovirus (HMPV).

“This commonly occurring virus causes respiratory illness and is in the same family of viruses as the respiratory syncytial virus (RSV). HMPV is detected all year round in South Africa as one of the regular seasonal respiratory viruses,” said the NICD, a division of the National Laboratory Service.

The virus is transmitted through respiratory droplets, much like RSV and influenza. 

HMPV is mostly associated with mild upper respiratory tract symptoms such as a cough, sore throat, runny nose, headache and possibly a fever. In most cases, these symptoms resolve within a few days. 

In some instances, HMPV may also cause infection in the lower respiratory tract (bronchitis/bronchiolitis or pneumonia). 

“HMPV is typically detected less commonly among patients presenting for care with respiratory illness compared to influenza or RSV, but this can vary depending on the time of year. 

“People who are at risk of the virus are infants who are under six months of age (specifically those who are born prematurely), older people, people with comorbidities such as chronic lung and heart disease, those with conditions that affect the immune system (such as HIV), and people with diabetes are at increased risk of developing severe illness,” said the NICD.

It said, as with most respiratory viral illnesses, there was no specific treatment for HMPV. 

Treatment of mild illness would include symptomatic relief, such as rest, medicines for pain and fever. People should also remain at home while ill to prevent the spread of respiratory viruses.

Should symptoms not resolve within 3 to 5 days or become severe (difficulty breathing, fever not settling), people should seek care at a clinic or general practitioner. 

More severe illnesses would be managed supportively with admission to the hospital for monitoring, supplementary oxygen and fluids as needed. 

The NICD said vaccines for HMPV are in the late stages of development. 

“There is also a combination vaccine (for HMPV and RSV) in development. These will likely be available in the next few years.”

The NICD has robust surveillance systems across South Africa, which will be able to detect an increase in respiratory pathogen circulation, and their laboratory has the capability to test for HMPV and other respiratory viruses. 

“Many private laboratories in South Africa can also test for HMPV and other respiratory viruses. In addition, in August 2024, multidisciplinary and multilevel stakeholders convened in Johannesburg, South Africa, to participate in a tabletop simulation exercise to test and refine the draft National Respiratory Pathogen Pandemic Plan. 

“Simulation exercises are essential for countries to test and validate their preparedness and response mechanisms for public health emergencies, including epidemics and pandemics,” it said. – SAnews.gov.za

Janine
Fri, 01/10/2025 - 10:06

7 views
Read moreNICD calls for calm amidst reported HMPV cases in China

SA reports surge in seasonal rubella cases among children

Location: News

SA reports surge in seasonal rubella cases among children

The National Institute for Communicable Diseases (NICD) has reported a significant rise in rubella cases across the country. 

By the end of September, the NICD identified over 8 700 IgM-positive cases.

Data indicates that 98% (8543 out of 8723) of these cases have affected children under 15 years old, with the majority occurring in the age group of five to nine years.

The Centre for Vaccines and Immunology (CVI) at the NICD has recorded a rise in rubella cases in 2024, exceeding the numbers from fever-rash surveillance since 2015.

“This surge is attributed to a large number of children entering 2024 without prior rubella exposure or vaccination,” said the NICD in a statement. 

The institute observed that the significant seasonal increase in rubella cases is due to the disease being transmitted through droplets containing the virus. 

Additionally, non-pharmaceutical interventions, such as lockdowns, social distancing, and mask-wearing implemented during the COVID-19 pandemic, disrupted the natural seasonal transmission patterns of rubella.

The NICD noted that between 2020 and 2022, almost no rubella cases were identified from the fever-rash surveillance. 

“Children who would have been infected with rubella over the past three years are now becoming infected with the infection.” 

Rubella is a mild, self-limiting infection that presents with fever and a maculopapular rash, myalgia, enlarged lymph nodes, headache and conjunctivitis. 

Occasionally, the NICD said people may develop joint pain or arthralgia, low platelets and mild encephalitis. 

Meanwhile, pregnant women who are susceptible to rubella or who have not been vaccinated against rubella nor had natural rubella infection at some point in their lives are at risk of passing rubella infection to their unborn child, resulting in “congenital rubella infection”. 

“Fortunately, this is uncommon, as studies have shown that up to 98% of women of childbearing age are immune to rubella.” 

The NICD explained that the congenital rubella syndrome may lead to foetal death or congenital abnormalities such as congenital heart disease, blindness and deafness. 

Any pregnant woman who has been exposed to a case of rubella, or a person with fever and rash should report this urgently to their health practitioner who will then conduct tests. 

“A pregnant woman who is diagnosed with rubella infection should undergo specialist obstetric evaluation.” 

Rubella is a notifiable medical condition and people meeting the case definition for rubella should be notified, and a blood specimen for rubella antibody testing should be sent to the NICD. 

“Specimens are routinely tested for measles and rubella,” the institute explained. 

Due to the backlog of tests at the NICD, the institute stated that priority rubella testing should be requested under three conditions.

A pregnant woman in her first trimester may need testing if she is exposed to someone with rubella or a person exhibiting fever and rash. 

In addition, testing is necessary for severely ill patients admitted to the hospital to rule out rubella or measles. 

Furthermore, testing is warranted if a newborn is suspected of having congenital rubella syndrome.

The specimen should be marked “Priority sample, urgently required.” 

Health practitioners are advised to email Busisiwe Masengemi at BusisiweM@nicd.ac.za (NICD receiving office), Jayendrie Thaver at jayendriet@nicd.ac.za, and Lillian Makhathini at LillianM@nicd.ac.za (both from the CVI laboratory) to request urgent testing. – SAnews.gov.za

 

Gabisile
Thu, 12/19/2024 - 14:58

242 views
Read moreSA reports surge in seasonal rubella cases among children

Health equity and women’s health emerge as key themes of the inaugural International Health Ministerial Summit

Location: News
Informa Markets: Healthcare

The inaugural International Health Ministerial Summit, organised by Informa Markets (www.InformaMarkets.com), began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative solutions to global healthcare challenges.

Hosting governmental figures and policymakers, corporate CEOs and investors, medical directors, and experts, the exclusive by-invitation only Summit, themed Strengthening Health Systems for a Better Tomorrow, takes place from 4 to 5 December 2024 at the Marriott in Kigali. It brings together renowned health experts from across the continent and the world and highlights topics like digital health, technological adoption, R&D in vaccinations, women's health, healthcare investment opportunities, and health equity.

During his official opening address, Dr. Sabin Nsanzimana, the Minister of Health of host country Rwanda, said: “There is no better investment than in our health. It is not a negotiable luxury but a fundamental human right. Strengthening health systems means focusing on the four S's: staff, space, supplies, and systems. In Rwanda, we understand that investing in health is investing in our future. That's why the Government of Rwanda has approved the 4x4 Reform—a bold strategy to quadruple the number of healthcare workers in the next four years to meet the WHO recommendation of at least 4 healthcare professionals per 1,000 population. This initiative underscores our commitment to building a resilient health system where no one is left behind. By investing in these pillars and embracing technology/innovations like AI, we can build resilient systems that ensure uninterrupted care for all.”

Addressing health equity's challenges and opportunities 

Following the welcome address by Dr. Deborah M. Barasa, Health Cabinet Secretary of Kenya, who spoke about actions to shift primary healthcare, the first session of the day featured several panel discussions dealing with the challenges and opportunities for health equity.

In a panel discussion hosted by Dr. Tim Keuri, CEO of the Kenya Health Federation, industry leaders discussed transforming Africa into a global hub for pharmaceutical innovation and manufacturing. Representatives from the Unified Procurement Association, PharmaAccess, Global One Health Institute, Pfizer, and Bayer provided insights on investment enhancement, regulatory framework improvements, and strategic collaborations to strengthen Africa's position in the global pharmaceutical value chain.

Another panel, moderated by Bloomberg news reporter Ondiro Oganga, addressed the urgent need for Africa to advance self-sufficiency in pharmaceutical R&D, local vaccine production, and diagnostic access. Experts from Senegal's Ministry of Health, The Global Trust Project, UN Foundation, African Society for Laboratory Medicine, Africa CDC, and leading corporations like Genf, Hologic, and Roche Diagnostics emphasised the importance of establishing regional pharma hubs and enhancing local capabilities. According to Ahmed Ogwell, Vice President of Global Health Strategy at the UN Foundation in Kenya, “The gap is not in identifying problems or proposing solutions—it's in executing those solutions. For example, while there's been significant discussion around manufacturing COVID-19 vaccines, we lack local production of diagnostics and essential tools like rapid tests on the continent. To move forward, we need to prioritise what to produce, coordinate efforts regionally, and ensure that the products we manufacture are consumed within our systems." 

Women's health and equitable access to healthcare

The second key theme of the day was health equity and women's health, starting with an insightful discussion on what is needed to close the health equity gap. Moderated by Dominic Wilhem, Executive Director of The Global Trust Project, global health leaders debated how to unite healthcare stakeholders to address the health equity gap. Panellists focused on collaborative strategies to ensure universal access to essential medicines and vaccines. The session underscored the importance of international cooperation to progress healthcare for all, regardless of geographic or socio-economic boundaries. Pfizer Kenya Director of Policy and Public Affairs Pauline Irungu commented on the outcomes, saying, “When we think about partnerships, we have a tendency to think about government- private partnerships, but we also need to talk more about private private partnerships which then support agendas of governments in Africa and beyond. At Pfizer one of the gaps we experience is the challenge of diagnostics. How do we advance access to medicine?  Currently , we have two strong partnerships  with diagnostic companies on the continent. Now we also make a call that we also want others to join the partnerships because the more we partner as private sector, the more  we're able to address the multifaceted challenges within the health care system.”

A second panel on the topic brought together top health experts to tackle the urgent issue of women's health in Africa, particularly the high maternal mortality rates in sub-Saharan Africa. Hosted by Dr. Magome Masike, Registrar, Health Professions Council of South Africa, this panel of leaders from various health organisations and government bodies debated the need for innovative approaches to enhance women's health across the continent. The session highlighted the importance of rethinking strategies to improve healthcare outcomes for women in Africa.

Day two of the Summit will focus on advancements in digital health, how artificial intelligence is transforming healthcare, health investment and financing, and an exciting Rwandan initiative using drones to deliver essential medicines to health facilities.

For more details on the International Health Ministerial Summit, visit the event website: https://apo-opa.co/3ZBts4y

Distributed by APO Group on behalf of Informa Markets: Healthcare.

Media files
Informa Markets: Healthcare
Download logo
Read moreHealth equity and women’s health emerge as key themes of the inaugural International Health Ministerial Summit

SAHPRA encourages citizens to report suspected side effects from medication

Location: News

SAHPRA encourages citizens to report suspected side effects from medication

The South African Health Products Regulatory Authority (SAHPRA) has encouraged citizens to always report any suspected side effects they may experience from taking medicines, vaccines or using medical devices, to help make medicines safer for everyone.  

While humanity benefits greatly from medicines in the treatment of illness and management of certain conditions, SAHPRA said medicines may at times cause side effects. 

However, according to the local drug watchdog, the risk of side effects and severe harm can be drastically reduced by taking medicines correctly and following the advice of a healthcare practitioner. 

SAHPRA, together with over 90 other medicines and health product regulators, as well as healthcare organisations globally, is participating in the annual MedSafety Week awareness initiative, which takes place between 04 and 10 November 2024. 

This year’s theme will focus on the importance of using medicines in the right way to prevent side effects and to report side effects when they do occur. 

The awareness is spearheaded by the Uppsala Monitoring Centre under the auspices of the World Health Organisation (WHO) Programme for International Drug Monitoring.

This is a programme that monitors and identifies adverse effects of medicines and vaccines, to reduce risks to patients, and to establish worldwide pharmacovigilance standards and systems. 

SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, said that handling and storing as well as taking medicines as directed by a healthcare professional is key in reducing the incidence of adverse reactions.

“Research shows that about half of all side effects are preventable. Patient safety is our top priority and during MedSafety Week, we wish to remind patients to take their medicines as instructed and healthcare professionals to review therapies as well as each patient’s unique health conditions before prescribing or dispensing medicines,” said Semete-Makokotlela.

SAHPRA called upon the South African public and healthcare professionals to use either the MedSafety app or the eReporting portal  - both accessible on  SAHPRA's website - to report suspected side effects from health products. 

According to the watchdog, all reports are assessed and examined to determine the correct steps to protect medicine users in South Africa from harm. 

“The purpose is to gain better knowledge about known side effects and to discover new ones. This can result in warnings and changes to how a medicine is used,” the authority explained. 

The SAHPRA MedSafety app and eReporting portal can be used for reporting suspected adverse drug reactions from medicines, vaccines, herbal products, biological medicines and any quality issues relating to health products. – SAnews.gov.za

 

Gabisile
Thu, 11/07/2024 - 13:12

20 views
Read moreSAHPRA encourages citizens to report suspected side effects from medication

dtic calls for a resilient health system

Location: News

dtic calls for a resilient health system

The Deputy Minister of Trade, Industry and Competition, Zuko Godlimpi, has called for a resilient health system that prioritises equitable access and sustainable solutions in times of crisis. 

He emphasised the need for fair and sustainable measures to equip health systems with the necessary "shock absorbers" to withstand future challenges. 

Godlimpi said it was clear with every health crisis faced as a country, region and world that sustainable ways must be found to strengthen health systems.  

He made these remarks during his address at the Annual General Meeting of the Innovative Pharmaceutical Association South Africa (IPASA), which took place in Johannesburg on Thursday.

Reflecting on the impact of recent global health challenges, Godlimpi emphasised that these crises, while affecting all, are not felt equally.

“The severity of their impact is determined by geopolitical and economic standings, often leaving vulnerable populations to bear the brunt.

During the height of the COVID-19 pandemic, South Africa, under President Cyril Ramaphosa’s leadership, championed vaccine justice on the world stage, asserting that access to vaccines and essential medicines should be a universal right,” Glodlimpi said.

He called for the development of robust domestic manufacturing capabilities, especially in pharmaceuticals and medical supplies to reduce reliance on external sources during global emergencies. 

The creation of a resilient healthcare system would not only secure the health of the population but would also drive job creation and economic growth.

“By investing in local manufacturing capacity, we secure our sovereignty in healthcare and strengthen our economy.

“Building a sustainable pharmaceutical industry cannot be achieved by government action alone. 

“We need active participation from industry leaders, multinational corporations and local innovators alike, and I commend IPASA’s contributions to promoting ethical standards and supporting a patient-centred healthcare system,” he said.

Godlimpi mentioned that as part of South Africa’s broader industrial strategy, the Department of Trade, Industry and Competition (the dtic) had implemented master plans to drive growth in key sectors.

“The MedTech Master Plan, launched in May, is one such initiative, aiming to bolster local manufacturing in the medical technology sector. The development of future master plans, including those for pharmaceuticals, biologics and vaccines, depends on collaboration with multinational corporations and industry stakeholders,” he said.

Emphasising the importance of local manufacturing, Godlimpi noted that currently, pharmaceutical imports account for a significant trade deficit.

“However, with the active participation of multinationals in localisation programmes, we can create a more self-reliant healthcare system and reduce our dependency on imports. 

“I also want to highlight opportunities within offset programmes, where foreign suppliers are encouraged to invest in local industry through technology transfer, local hubs, and third-party manufacturing,” he said. – SAnews.gov.za

Edwin
Fri, 11/01/2024 - 09:44

14 views
Read moredtic calls for a resilient health system

African leaders meet on Mpox

Location: News

African leaders meet on Mpox

President Cyril Ramaphosa says as the continent tackles Mpox, Africa needs to learn from the COVID-19 pandemic.

“We need to ensure equitable distribution of medical countermeasures based on transparent criteria and readiness to initiate vaccination. We ask Africa Centres for Disease Control and Prevention (Africa CDC) to lead the consultation with member states to ensure equitable distribution of vaccines and other medical countermeasures,” said the President.

He was delivering South Africa’s statement at the African Union Heads of State virtual meeting on Mpox on Sunday.

“We need a finance plan that is evidence-based, with sound forecasting of needs. The Africa CDC mandate on data sharing is the bedrock of global health security. This will help to ensure that public health threats are detected and shared across borders and with other continental and global stakeholders,” said the President.

He said countries would only be able to effectively mobilise and direct funds if supported by reliable data.

“We call on all African countries to make use of this instrumental system that has been created by our own institution. We call for the urgent operationalisation of the Africa Epidemic Fund as the primary vehicle for epidemic response financial management.”

He said as with COVID-19, Africa is still struggling to get the Mpox vaccine and treatment.

The President said the continent needs to manufacture Mpox vaccines in Africa to reduce costs and improve access.

“We must co-develop these medical countermeasures, share intellectual property and ensure technology transfer. In this regard, we welcome the agreement between Africa CDC and Bavarian Nordic to transfer the Mpox vaccine technology to African manufacturers,” he said.

With the financial support from the Coalition for Epidemic Preparedness, the African Vaccine Manufacturing Accelerator, Afreximbank, the European Union and other partners, President Ramaphosa said the continent should be able to start vaccine manufacturing by 2025.

“In the meantime, we appreciate the support from a number of countries to get vaccines in Africa.

“The COVID-19 experience taught us that we need predictable demand and off-take guarantees for the vaccines, medicines and diagnostics manufactured in Africa. African countries should therefore buy vaccines and other health products manufactured in Africa to ensure sustainable manufacturing on our continent.”

He said this could be achieved through the African Pooled Procurement Mechanism.

Surveillance systems must be enhanced and healthcare delivery and infrastructure strengthened.

“We must ensure that frontline health workers have the necessary diagnostic tools, vaccines and antiviral treatments. We need tested public health messages that promote awareness and prevention.

“Beyond the targeted vaccination responses to outbreaks, we should explore the feasibility of continuing vaccinations in high-risk populations. This dual approach will help create a buffer against future outbreaks and protect our most vulnerable communities,” he said.

The World Health Organisation (WHO) has declared Mpox  as a Public Health Emergency of International Concern.

The President commended the fact that Africa CDC had partnered with the WHO, UNICEF and other partners to develop the Mpox continental preparedness and response plan and to build, for the first time in Africa, one Continental Incident Management Team.

The total number of positive cases recorded in South Africa since the outbreak in May this year stands at 25 cases, including three deaths. Twelve of these were reported in Gauteng, 11 reported in KwaZulu-Natal and two in the Western Cape.

Africa CDC has signed a partnership agreement with the European Commission’s Health Emergency Preparedness and Response Authority (HERA) and Bavarian Nordic to provide over 215 000 doses of the MVA-BN vaccine.

Africa CDC will oversee the equitable distribution of these vaccines, prioritising local needs across the affected member states. – SAnews.gov.za

 

Janine
Mon, 09/23/2024 - 11:17

760 views
Read moreAfrican leaders meet on Mpox

South Africa Makes Strides in Bid to Contain Mpox

Location: News
World Health Organization (WHO) - South Africa

As the wider African region experiences an upsurge in mpox cases, South Africa's multi-pronged efforts to bring the outbreak under control are bearing fruit. On 14 August 2024, World Health Organization (WHO) declared mpox a public health emergency of international concern and subsequently issued a set of temporary recommendations to scale up the emergency response.

South Africa had previously reported five unlinked mpox cases in 2022. Having confirmed zero cases in 2023, the country has experienced a resurgence of the infectious disease in recent months, reporting 25 laboratory-confirmed cases and three deaths between 8 May and 6 September 2024. These cases have been reported in Gauteng, Western Cape, and KwaZulu-Natal provinces, with local transmission suggested for 24 cases and one imported case. 

However, there has been a significant change in the epidemiological data in recent weeks, with just one new case and no deaths reported since 2 August 2024, compared to 12 cases and three deaths in June, so far, the peak of the current outbreak. 

“With the support of partners including WHO, we have made significant progress in our efforts to contain mpox in the country,” says Foster Mohale, spokesperson for South Africa's National Department of Health. “But we must not become complacent because viruses mutate from time to time. The recent detection of a new mpox case in Western Cape should be a strong reminder that we must all remain extremely vigilant.”

To coordinate its response to the outbreak, the National Department of Health formed an mpox Incident Management Team comprised of experts from national and provincial levels and partners including WHO. In June, with WHO support, health authorities conducted two remote webinars on clinical management of mpox cases, training over 500 health workers and public health professionals. 
The department has also activated provincial response teams to implement priority interventions in hotspots, deployed rapid response teams to support community surveillance and case management, and intensified targeted public awareness campaigns. 

In addition to providing technical support and guidelines on mpox treatment to help ensure standardized patient care, WHO has donated 35 treatment courses of tecovirimat, an antiviral that is used to treat severe mpox cases in conjunction with symptomatic and supportive care. The Organization is supporting efforts to stockpile an additional 30 treatment courses of the medication for rapid deployment should further cases arise. 

South Africa is one of 14 countries in the African region that will be financially supported by the Africa Centres for Disease Control and Prevention (Africa CDC) and WHO from September 2024 until February 2025 to draw up and roll out plans, including vaccination strategies, to continue its fight against mpox. The Mpox Continental Preparedness and Response Plan for Africa will see an estimated US$ 45.5 of a US$ 600-million total budget allocated to South Africa, most of which will be spent on the logistics of rolling out vaccines.  

“WHO remains committed to supporting health authorities in containing the mpox outbreak through coordinated efforts in treatment, surveillance, and public awareness,” says Dr Fabian Ndenzako, acting WHO Representative in South Africa. “I am pleased to see mpox control efforts targeting health workers, community members and key risk populations to prevent further transmission and manage this public health issue effectively.”

Distributed by APO Group on behalf of World Health Organization (WHO) - South Africa.

Media files
World Health Organization (WHO) - South Africa
Download logo
Read moreSouth Africa Makes Strides in Bid to Contain Mpox

Mpox no threat to Africa Aerospace and Defence Expo

Location: News

Mpox no threat to Africa Aerospace and Defence Expo

The highly anticipated Africa Aerospace and Defence (AAD) Expo and Air Show, which takes place from 18-22 September 2024, is under no threat from the mpox outbreak, according to the event organisers.

Mpox has seen a resurgence in South Africa in 2024 after no reported cases in 2023.

As of 18 August 2024, South Africa has recorded 24 cases, including three fatalities. 

The country has since logged 19 recoveries, and only two active cases are currently undergoing home isolation.

“While the numbers are low, the re-emergence of mpox underscores the importance of continued vigilance,” the statement read. 

The Department of Health, in collaboration with international organisations such as the World Health Organisation (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC), has taken robust measures to contain and manage the virus. 

These measures include enhanced testing, isolation protocols, and community engagement efforts to educate the public and reduce stigma. 

“Currently, there is no indication that the mpox virus will significantly impact or pose a direct threat to the upcoming AAD Expo. 

“The low number of active cases and the high recovery rate indicate that the situation is under control. We are closely monitoring developments to ensure the safety of all participants,” said AAD Exhibition Director, Nakedi Phasha. 

Organisers have since reassured expo visitors that there is no need to panic. 

“South African health authorities have effectively managed similar outbreaks in the past and continue to employ effective strategies, such as isolation, contact tracing, and appropriate medical treatment, to contain the virus. By following public health advice and maintaining awareness, the risk of a broader outbreak remains low.” 

Meanwhile, the organisers said they are committed to ensuring a safe and successful event for everyone involved. 

“The AAD Expo 2024 will proceed with all necessary precautions in place, and we are confident that, with your cooperation, we can enjoy a productive and memorable experience.”

According to the Department of Health, mpox presents with a range of symptoms that can vary in severity. 

The symptoms often appear within seven to 14 days after exposure but can take up to 21 days to manifest. 

“If you notice symptoms such as fever, headache, muscle aches, back pain, swollen lymph nodes, and especially the characteristic rash associated with mpox, it is crucial to isolate yourself immediately and seek medical attention for a proper diagnosis. Early isolation and treatment are key to preventing the spread of the virus and ensuring your health and safety.” 

The department has urged people who experience any of the mpox symptoms, with or without international travel history to present themselves to a health facility for clinical observation and confine themselves to one place until their test results are available.

Meanwhile, to address the mpox outbreak in Africa, the Africa Centres for Disease Control and Prevention (Africa CDC) has set up a 25-member incident management unit to support affected and at-risk countries. 
Africa CDC has signed a partnership agreement with the European Commission’s Health Emergency

Preparedness and Response Authority (HERA) and Bavarian Nordic to provide over 215 000 doses of the MVA-BN vaccine. 

Africa CDC will oversee the equitable distribution of these vaccines, prioritising local needs across the affected Member States. – SAnews.gov.za

Gabisile
Fri, 09/06/2024 - 14:37

138 views
Read moreMpox no threat to Africa Aerospace and Defence Expo

Cabinet welcomes signing of second Presidential Health Compact

Location: News

Cabinet welcomes signing of second Presidential Health Compact

The quest for quality and affordable healthcare for all has moved closer with the signing of the second Presidential Health Compact.

This is according to the Acting Minister in the Presidency, Maropene Ramokgopa, who addressed media on Thursday on the outcomes of the Cabinet meeting held on Wednesday.

Last month, Deputy President Paul Mashatile, in his capacity as Acting President, presided over the signing of the second Presidential Health Compact, an initiative established by President Cyril Ramaphosa in 2019.

READ | A nation's health, is a nation's wealth

The health compact is a framework for cooperation between critical sectors and stakeholders to strengthen the health system. It monitors and evaluates preparations for the implementation of the National Health Insurance (NHI).

The stakeholders include government, business, labour, civil society, health professionals, unions, service users, statutory councils, academia and researchers to develop sustainable and inclusive solutions to challenges in the national health system.

“It seeks to strengthen the health system and monitors and evaluates preparations for implementing the NHI,” Ramokgopa said. 

The health compact also seeks to bolster the development of human resources, while improving access to medicine, vaccines and health products, upgrading infrastructure and ensuring private sector engagement.

The Acting President told the delegates during the signing ceremony that a healthy nation is more economically productive and prosperous.

“A healthy population enjoys higher life expectancy, better quality of life and overall wellbeing. As a result, providing quality healthcare is of the utmost importance to all of us,” he said. 

Meanwhile, Ramokgopa said Cabinet was appalled that some unscrupulous and greedy lawyers and advocates have attempted to defraud billions of rands from the State through fraudulent and irregular medico-legal claims.

READ | Medico-legal claims a feeding trough for unscrupulous legal practitioners

“These wrongdoings were uncovered in a far-reaching investigation by the SIU [Special Investigating Unit] into alleged fraudulent medico-legal claims against the State since 2017.” 

According to the Minister, the ongoing investigation revealed that some legal practitioners are helped by health practitioners working for the State to target the department.  

In addition, she said matters completed by the SIU have resulted in at least R3 billion in savings for various provincial health departments. – SAnews.gov.za

Gabisile
Thu, 09/05/2024 - 11:43

242 views
Read moreCabinet welcomes signing of second Presidential Health Compact

Motsoaledi calls on pharmacists to play a role in vaccine manufacturing

Location: News

Motsoaledi calls on pharmacists to play a role in vaccine manufacturing

Department of Health Minister, Dr Aaron Motsoaledi, has called on pharmacists to play an active role in vaccine manufacturing as the world grapples with a growing trend of infectious diseases. 

“The world is seriously crying for vaccines and medicines – affordable ones for that matter. Should we be squabbling with each other like we did during COVID-19?” the Minister retorted.

The Minister was speaking at the opening of the first-ever Pharmacists International Federation (FIP) Congress held in Cape Town on Monday.

The four-day congress, which kickstarted on Sunday is also part of the Pharmacy Month commemorative activities to raise patient awareness of the vital role pharmacists can play in the community’s healthcare and to improve communication between patients and pharmacists and pharmacy support personnel.

READ | Motsoaledi to open Pharmacists International Federation Congress

“When the need arises for all humanity to be vaccinated, should the vaccines be so scarce that the developed world starts hoarding them for themselves, leaving the still developing world on their own? Surely, we can do better than this and it is within our capability to do better,” he told delegates. 

“I have full confidence that in your deliberations, those facts will not just be shoved away and kept under the carpet, for there is a lot at stake for all humanity.”

He told the attendees that he believes that in the next 10 to 15 years the world will have defeated modern-day infectious diseases like HIV and Aids, Ebola, Mpox, tuberculosis, malaria and others.

“But in doing this, as The Lancet states, we shall be ushering in a new era of non-communicable diseases (NCDs). You shall be called again to provide easily accessible and affordable pharmaceuticals to deal with these NCDs, which are, already upon us.

“The question is: are we equal to the job? Shall we rise to the occasion?” 

Motsoaledi also touched on the need to address health inequities across the world, urgently strengthening health systems and the need to harness innovation and technology to transform health systems. 

The Minister also spoke about the need to invest in sustainable and equitable health financing and using healthcare as a public good and as part of social justice. 

“Let us remember that as pharmacists, we are not just being distributors but also serve as instructors, patient safety advocates and important participants in public health campaigns.

“I call upon every one of you to be agents of change,” he stressed. 

The Minister challenged the pharmacists to ensure the health systems are not just of good quality but are also equitable and inclusive. 

“This is a call to advocate for policies that prioritise the needs of the most vulnerable, and in the process, commit to advancing the pharmacy profession as a driving force for health equity and quality care.”

He also took the time to express his gratitude to the FIP for bringing the congress to Cape Town and to all the delegates for their commitment to improving healthcare through the pharmacy profession. 

“We hope that your decisions over the next few days will shape the future of health. I wish you all a productive and inspiring experience at congress, and I look forward to seeing the innovative solutions and partnerships that will emerge from our time together.” – SAnews.gov.za
 

Gabisile
Tue, 09/03/2024 - 09:29

343 views
Read moreMotsoaledi calls on pharmacists to play a role in vaccine manufacturing

Motsoaledi to open Pharmacists International Federation Congress

Location: News

Motsoaledi to open Pharmacists International Federation Congress

South Africa is hosting the first-ever International Pharmaceutical Federation (FIP) Congress in sub-Saharan Africa. 

The four-day congress, which kick-started on Sunday, 1 September 2024, is also part of the Pharmacy Month commemorative activities to raise patient awareness of the vital role pharmacists can play in the community’s healthcare and to improve communication between patients and pharmacists and pharmacy support personnel.

The gathering brings together pharmacists from all over the world to share expertise, network, share knowledge technology innovations and experience.

Health Minister, Dr Aaron Motsoaledi, is expected to deliver a keynote address at the official opening of the congress today. The gathering is being held at the Cape Town International Convention Centre. 

The FIP is a non-governmental organisation representing over four million pharmacists and pharmaceutical scientists and has been recognised by the World Health Organisation (WHO) since 1948. 

It partners with some of the world’s leading health, policy-making, education and science institutions.

“During the congress, pharmacists from different backgrounds will have the opportunity to share expertise and knowledge to advance the profession to meet the healthcare needs in the challenging environment of endless disease outbreaks.”

According to the Department of Health, pharmacists play an important role in the healthcare sector as they also  foresee innovation in medicine such as vaccines which are critical in saving people’s lives, especially during outbreaks and pandemics as was the case during the COVID-19 pandemic. 

Pharmacists are often the first point of contact for medicines dispensation due to their medication expertise, patient access, and medication management responsibilities.

This year’s Pharmacy Month is commemorated under the theme: ‘Let’s Talk About Vaccines’. 

Meanwhile, the FIP Congress’ theme will focus on innovating for the future of healthcare. 

The theme is based on the conviction that improving vaccination coverage and promoting a life-course approach to vaccination are global imperatives to which pharmacists can greatly contribute.

Pharmacists play an important role in promoting vaccination, raising awareness and educating the population about the health, social and humanistic benefits of vaccines, including gains in quality of life.

Participating stakeholders at the congress include the South African Pharmacy Council, the Pharmaceutical Society of South Africa and the Independent Community Pharmacy Association. – SAnews.gov.za

Gabisile
Mon, 09/02/2024 - 09:59

180 views
Read moreMotsoaledi to open Pharmacists International Federation Congress

Following Directives From His Highness the UAE President Dispatches Vaccines to Five Countries in Africa to Combat the Outbreak of Monkeypox

Location: News

United Arab Emirates Ministry of Foreign Affairs & International Cooperation
Download logo

Following the directives of His Highness Sheikh Mohamed bin Zayed Al Nahyan, UAE President, and as part of the country's continuous humanitarian efforts to support other nations in confronting challenges and crises, the UAE has  dispatched several aircraft carrying Monkeypox vaccines to the Democratic Republic of the Congo, Nigeria, South Africa, Côte d'Ivoire, and Cameroon, to support their efforts to address and contain the outbreak of the virus.

His Excellency Sheikh Shakhboot bin Nahyan Al Nahyan, Minister of State, said: “The support offered highlights the significant importance placed by the UAE on enhancing global humanitarian and healthcare efforts, and affirms the country's steadfast commitment to assisting other nations during crises and disasters."

His Excellency added: “The initiative reflects the UAE's commitment to humanitarian values as part of its ongoing commitment to extend a helping hand and assist impacted communities across the world."

Distributed by APO Group on behalf of United Arab Emirates Ministry of Foreign Affairs & International Cooperation.

Read moreFollowing Directives From His Highness the UAE President Dispatches Vaccines to Five Countries in Africa to Combat the Outbreak of Monkeypox

Department calls for child immunisation against rubella as cases rise

Location: News

Department calls for child immunisation against rubella as cases rise

The Department of Health has urged parents and caregivers to ensure children are up to date with vaccination schedules against serious diseases that are prevented by vaccines as the country is experiencing an increase in rubella cases in some provinces.

The National Institute for Communicable Diseases (NICD) has alerted the department of the notable rising number of rubella cases in various parts of Gauteng, Western Cape, Eastern Cape and KwaZulu-Natal.

Rubella, otherwise known as German measles, is an infectious disease caused by the rubella virus. 

According to the department, it is usually a mild disease in children and adults but can have serious consequences in pregnant women by infecting their unborn babies and causing congenital rubella syndrome.

“The disease primarily spreads through respiratory droplets from coughing or sneezing and can also be transmitted from mother to foetus during pregnancy.” 

The department said it generally causes a mild illness in children and adults, characterised by a low-grade fever, rash, and sometimes joint pain. 

It can lead to congenital rubella syndrome in the fetus, resulting in death, miscarriages, stillbirth or severe birth defects in infants. 

The department explained that the incubation period of rubella ranges from 14 to 21 days.

In recent weeks, the department said it has received enquiries following the closure of schools in the Northern Cape after a rubella case was detected amongst school learners. 

“Although proactive and effective measures to prevent further spread of the disease are always recommended, the school closure should only be implemented as the last resort after all measures have been employed.

“Children who develop symptoms including nausea, sore throat, red eyes and swollen lymph nodes in the neck, compatible with rubella should be treated symptomatically and remain away from school until they recover.” 

According to the department, all suspected rubella cases should be reported to the nearest health facility or healthcare provider, who will then notify the department using the Notifiable Medical Conditions reporting platforms.

In the meantime, the department is currently rolling out the measles-rubella vaccine as part of the Expanded Programme of Immunisation. 

“This combined vaccine replaces the standalone measles vaccine and is administered at six and 12 months of age. In the private sector, rubella protection is included in the MMR [measles, mumps, rubella] vaccine, which is typically given between 12 and 15 months of age.” – SAnews.gov.za

Gabisile
Thu, 08/29/2024 - 14:55

313 views
Read moreDepartment calls for child immunisation against rubella as cases rise

SA’s Mpox disease under control, Cabinet

Location: News

SA’s Mpox disease under control, Cabinet

Cabinet has moved to reassure South Africans that the Mpox outbreak is under control.

The disease has now been declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organisation (WHO) and a Public Health Emergency of Continental Security (PHECS) by the Africa Centres for Disease Control and Prevention (Africa CDC).

Addressing the media during a post-Cabinet media briefing in Pretoria on Thursday, Minister in The Presidency, Khumbudzo Ntshavheni reported that to date, the total number of positive cases recorded in South Africa stands at 24.

The cases include three deaths, 19 recoveries and two active cases undergoing home isolation.

“Of these, 12 cases were reported in Gauteng, 11 in KwaZulu-Natal and one in the Western Cape,” Ntshavheni said.

Cabinet has called on members of the public to play their part by supporting the government’s efforts to prevent the spread of Mpox by remaining vigilant and exercising non-pharmaceutical interventions such as heightened personal hygiene to prevent further transmission.

“Cabinet supports the call by President Cyril Ramaphosa in his capacity as the African Union (AU) Champion on Pandemic Prevention, Preparedness, and Response for all partners to collaborate closely with the Africa CDC to ensure that there is appropriate support from the international community, guaranteeing equitable access to medical countermeasures, including diagnostics, therapeutics and vaccines,” the Minister said.

READ | Mpox is under control: Department of Health 

Tackling foot-and-mouth disease 

Cabinet has also noted major progress made in tackling foot and mouth disease (FMD) in the Kouga and Kou-Kamma Local Municipalities in the Eastern Cape, with the last clinical case reported in mid-July.

Ntshavheni said animal movements in and out of the affected regions continues to be monitored to prevent the spread of the disease to unaffected areas, in terms of the Disease Management Area, and the transportation of livestock from one place to another [which] requires a transport permit from a local state veterinary office, to prevent the spread of the disease.

READ | Progress made in management of foot and mouth disease

“The 30 cattle farms that have tested positive for the disease have been placed under quarantine, and vaccination efforts continue to control the spread of infection and reduce the severity of clinical symptoms.

“Additionally, pre-emptive vaccination has been carried out on a further 37 farms identified as high risk due to their proximity to infected areas. In total, over 92 000 cattle and nearly 600 sheep across 67 farms have been vaccinated,” Ntshavheni said. – SAnews.gov.za

GabiK
Thu, 08/22/2024 - 13:53

517 views
Read moreSA’s Mpox disease under control, Cabinet

A nation’s health, is a nation’s wealth

Location: News

A nation's health, is a nation's wealth

South Africa’s health system is too essential to development to be weakened by mismanagement, funding crises, and other problems.

“We expect all stakeholders to bring solutions and work with the Departments of Health and Science and Innovation to implement them,” said Acting President Paul Mashatile on Thursday.

The Acting President was speaking at the Union Buildings in Pretoria, where he presided over the signing of the second Presidential Health Compact, an initiative established by President Cyril Ramaphosa in 2019.

The health compact is a framework for cooperation between critical sectors and stakeholders to strengthen the health system and monitors and evaluates preparations for implementing the National Health Insurance (NHI).

The stakeholders include government, business, labour, civil society, health professionals, unions, service users, statutory councils, academia, and researchers to develop sustainable and inclusive solutions to challenges in the national health system.

Its pillars range from the development of human resources, improving access to medicine, vaccines and health products, upgrading infrastructure and private sector engagement. 

It also zooms in on quality healthcare, public sector financial management improvements, governance and leadership, community engagements, and information systems to pandemic preparedness.

The Acting President told delegates present that implementation was the foremost priority of the country's seventh administration. 

“Effective policy implementation means we can take the right actions and follow through with the plans, leading to successful outcomes. I have full confidence that implementation is the priority of all of us gathered here today.

“On behalf of President Cyril Ramaphosa, it is my privilege to sign the second Presidential Health Compact today.”

He said he believed that a healthy nation is more economically productive and prosperous.

“A healthy population enjoys higher life expectancy, better quality of life and overall wellbeing. As a result, providing quality healthcare is of the utmost importance to all of us,” he added. 

Universal healthcare coverage

He said Africa is committed to the achievement of the United Nations Sustainable Development Goal of “ensuring healthy lives and promoting wellbeing for all at all ages”. 

“This is a bold commitment to achieve universal health coverage. It is a commitment to provide access to affordable medicines and vaccines for all. If our nation’s health is truly to be our nation’s wealth, we must fix our healthcare system.”

He said fixing the healthcare system will effectively protect the population against public health emergencies, such as HIV/AIDS, COVID-19, or Mpox.

The Acting President also outlined challenges that prevent government from providing decent and quality healthcare to all South Africans. 

Lack of funding and collaboration

He also touched on healthcare funding challenges due to budget cuts and a constrained fiscal environment, compounded by inefficiencies, mismanagement and corruption in resource allocation.

However, the Acting President said budgeting in the health sector is steadily improving to ensure a more equitable allocation of resources. 

“Less money is being lost to litigation. This is thanks to the hard work of the Health Sector Anti-Corruption Forum, which continues to expedite prosecutions and recover stolen funds.” 

With greater collaboration, he said the resources and capabilities of both the public and private sectors can be brought to bear to serve those who need healthcare most. 

However, some progress has been made as well with 149 new primary healthcare facilities being completed by November 2023. 

In addition, 30 new hospitals are either opened or under construction.

The Acting President also took the time to applaud the private sector for the crucial role it plays in strengthening health systems. 

“Our experience with COVID-19 showed how we could deepen public-private partnerships. With greater collaboration, the resources and capabilities of both the public and private sectors can be brought to bear to serve those who need healthcare most,” he added. – SAnews.gov.za

Gabisile
Thu, 08/22/2024 - 14:43

279 views
Read moreA nation’s health, is a nation’s wealth

President Ramaphosa to officiate signing of second Presidential Health Compact

Location: News

President Ramaphosa to officiate signing of second Presidential Health Compact

President Cyril Ramaphosa will on Thursday preside over the signing of the second Presidential Health Compact at the Union Buildings in Pretoria.

The Presidential Health Compact is an initiative established by President Ramaphosa in 2019. 

It is a framework of cooperation between critical sectors in South Africa that significantly influences good health outcomes. 

According to the Presidency, it also monitors and evaluates components where roles and responsibilities are assigned to various stakeholders to support the strengthening of health systems and preparation for implementing the National Health Insurance (NHI).

READ | President Ramaphosa to officiate signing of the Presidential Health Compact

The second compact follows the 2023 Presidential Health Summit, which built on the inaugural summit of 2018 and brought together several stakeholders. 

These include government, business, labour, civil society, health professionals, unions, service users, statutory councils, academia, and researchers to develop sustainable and inclusive solutions to challenges in the national health system.

The stakeholders involved in this framework are integral to supporting the Department of Health in improving the health system.

It initially consisted of nine pillars, with the 10th pillar added during last year’s summit. 

These include the development of human resources, improving access to medicine, vaccines and health products, upgrading infrastructure, private sector engagement, quality healthcare, public sector financial management improvements, governance and leadership, community engagements, information systems and pandemic preparedness. 

The signatories to the health compact are:

•    The President of the Republic of South Africa

•    The Minister of Health

•    The Minister of Science and Innovation

•    Independent Community Pharmacy Association (ICPA) 

•    South African National AIDS Council (SANAC)

•    South African Medical Association Trade Union

•    Democratic Nurses of South Africa

•    Congress of South African Trade Unions

•    Campaigning for Cancer- Patient User Groups

•    South African Medical Research Council (SAMRC)

•    South African Pharmacy Council (SAPC)

•    National Unitary Professional Association for African Traditional Health Practitioners of South Africa (NUPAATHPSA)

•    Traditional Knowledge Systems and Allied Health

The signing of the second Presidential Health Compact will take place at the Union Buildings Courtyard, West Wing, Pretoria at 12:30 pm. – SAnews.gov.za

Gabisile
Tue, 08/20/2024 - 09:44

273 views
Read morePresident Ramaphosa to officiate signing of second Presidential Health Compact

Mpox is under control: Depart of Health 

Location: News

Mpox is under control: Depart of Health 

The Department of Health has assured South Africans that the current Mpox outbreak remains under control. 

“However, this does not mean people should become complacent because we have learned from the COVID-19 pandemic that viruses are unpredictable as they mutate from time to time.” 

According to the department, South Africa remains on high alert in case of a surge in Mpox cases and the emergence of new contagious strains. 

The department has since called on citizens to play their part and support the country’s response efforts to prevent the spread of Mpox by maintaining nonpharmaceutical measures, including personal hygiene. 

Meanwhile, various pharmaceutical interventions, including additional treatments and vaccines, are being considered. The decision will be based on epidemiological data, the department added. 

The department also clarified that both the declarations by the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organisation (WHO) do not translate into trade and travel restrictions. 

This is after the ongoing outbreak of Mpox has been officially declared a Public Health Emergency of International Concern (PHEIC) by the WHO. 

The department said this serves as a clarion call for Member States, including South Africa, to work together, fast-track approval of Mpox vaccine and treatment while maintaining strict safety protocols, and ensuring these life-saving vaccines reach the most vulnerable populations to prevent the further spread of this infectious, but treatable disease. 

South Africa is also working with various stakeholders, including the WHO County Office, National Institute for Communicable Diseases (NICD) and Border Management Authority (BMA) to intensify epidemiological and surveillance, contact tracing and health screening activities for case investigation and early detection of new positive cases in the country.

The total number of positive cases recorded in the country as of Sunday, 18 August 2024, stands at 24 including three deaths, 19 recoveries and two active cases undergoing home isolation. 

Twelve cases were reported in Gauteng, 11 in KwaZulu-Natal and one in the Western Cape.

“The department will keep the public updated on the situation and response efforts, including as and when there are new developments. 

“We encourage businesses and organisations with operations in the affected countries to ensure [they] put measures in place to ensure their employees who regularly travel to and from South Africa, are well informed of Mpox; and are fit to travel.” 

Symptoms

In addition, travellers experiencing Mpox-like symptoms should seek immediate medical attention and if possible, delay their travel until they are diagnosed or fully recovered to prevent possible cross-border transmission.

“We also urge all people who experience any of the Mpox symptoms, with or without international travel history to present themselves to a health facility for clinical observation and confine themselves to one place until their test results are available.”

The department stated that anyone can contract Mpox regardless of age, gender, sexual orientation and race. 
“The current epidemiological data suggests that people living with HIV and men who have sex with men (MSM) are vulnerable to Mpox,” the department said, adding that those living with chronic medical conditions such as tuberculosis and diabetes are also at risk.

Some of the common symptoms of Mpox include a rash which may last for two to four weeks, fever, headache, muscle aches, back pain, low energy and swollen glands. 

According to the department, the painful rash looks like blisters or sores and can affect the face, palms of the hands, soles of the feet and groin. – SAnews.gov.za
 

Gabisile
Mon, 08/19/2024 - 09:51

503 views
Read moreMpox is under control: Depart of Health 

President Ramaphosa raises concern over rise of Mpox in AU region

Location: News

President Ramaphosa raises concern over rise of Mpox in AU region

President Cyril Ramaphosa  has expressed deep concern about the rapid spread of Mpox across the African Union (AU) region, as both cases and deaths continue to surge, reflecting a concerning shift in the epidemiological pattern.

The President was speaking in his role as the AU Champion on Pandemic Prevention, Preparedness, and Response (PPPR) regarding the Mpox outbreak.

“In my role as the AU Champion on PPPR, I have been closely monitoring the evolving Mpox situation, regularly briefed by the Director-General of Africa CDC and PPPR Commission,” he said in a statement on Saturday.

Since the start of 2024, he said 17 541 cases (2 822 confirmed and 14 719 suspected) and 517 deaths due to Mpox have been reported across 13 AU Member States. 

This week, three additional countries notified cases under investigation for confirmation, which brings the total to 16 countries. 

“Alarmingly, the number of reported cases in 2024 has surged by 160% compared to the same period in 2023.” 

Strengthening the response to Mpox

He said that he fully backs the Director-General of the Africa Centres for Disease Control and Prevention’s (Africa CDC) declaration of Mpox as a Public Health Emergency of Continental Security. 

“This crucial decision empowers Africa CDC to lead and coordinate our collective response efforts, strengthening the Mpox response at every level – from community engagement to collaboration with the highest political authorities and our international partners.” 

He believes that the declaration will also galvanise political leadership and engagement among AU Heads of State and Government, facilitating the rapid mobilisation of essential financial and technical resources. 

The President also commended the Permanent Representatives Committee for their decisive action in releasing US$ 10.4 million from the COVID-19 Fund to support the Mpox outbreak response. 

“I urge the AU policy organs to expedite the finalisation of the framework for operationalising the African Epidemic Fund, as approved by the Heads of State during the 2023 AU Assembly, by the end of August 2024.” 

The President has since called the AU Member States to increase domestic resource allocation, lead their national Mpox outbreak responses and enhance their capacities. 

These capabilities include building capacity, risk communication, community engagement, case detection, contact tracing, and cross-border surveillance. 

Public Health Emergency of International Concern

He also welcomed the World Health Organisation’s (WHO) declaration of Mpox as a Public Health Emergency of International Concern (PHEIC). 

READ | WHO declares mpox outbreaks in Africa a global health emergency

The WHO said the upsurge of Mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries constitute a PHEIC under the International Health Regulations (IHR).

However, the President said this PHEIC “must be different and correct the unfair treatment from the previous one declared in 2022, where vaccines and therapeutics were developed and made available primarily to Western countries, with little support extended to Africa”.

President Ramaphosa has since called upon WHO and all partners to collaborate closely with Africa CDC to ensure that this PHEIC unlocks appropriate support from the international community, guaranteeing equitable access to medical countermeasures, including diagnostics, therapeutics, and vaccines. 

He also urged the international community, partners, and organisations to mobilise stockpiles of vaccines and other medical countermeasures for deployment in Africa, utilising the mechanisms established by Africa CDC to ensure equitable distribution, transparency, and coordination.

The President said Africa requires robust support in funding, research, and the sharing of technologies, with financial contributions directed to the Africa Epidemic Fund under the leadership of Africa CDC. 

Pandemic Agreement 

“This is also an opportunity to call on the international community to finalise a fair and equitable Pandemic Agreement – a duty that must be pursued with urgency and a spirit of equity. 

“By fostering global partnerships, we can accelerate Africa’s response and ensure that all nations, regardless of economic status, have fair access to the resources needed to protect their populations.”

As the AU Champion, he vowed to work closely with his esteemed colleagues to ensure adequate political support and fundraising for the continental response to mpox and to prevent a regional and global pandemic. – SAnews.gov.za

Gabisile
Sun, 08/18/2024 - 11:38

374 views
Read morePresident Ramaphosa raises concern over rise of Mpox in AU region